Pengkai Ma
Overview
Explore the profile of Pengkai Ma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
101
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang X, Jing Z, Huang X, Liu X, Zhang Y, Wang Z, et al.
Int J Pharm
. 2024 Nov;
667(Pt B):125004.
PMID: 39608587
Purpose: Combination immune checkpoint inhibitors (ICI) with chemotherapeutic agents has proven to be highly promising in cancer therapy. However, low response rate, immune-related adverse events, and lack of effectively targeted...
2.
Wang B, Wu K, Liu R, Huang Y, Chang Z, Gao Y, et al.
Molecules
. 2023 Nov;
28(21).
PMID: 37959818
The objective of the present study was to develop PTF-loaded solid lipid nanoparticles (PTF-SLNs) and investigate their efficacy in treating lung cancer. The PTF-SLNs were prepared by the thin film...
3.
Chen R, Li L, Li Y, Song K, Shen C, Ma P, et al.
J Gastrointest Oncol
. 2022 Jul;
13(3):1367-1375.
PMID: 35837188
Background: Repeated transcatheter arterial chemoembolization (TACE) could cause ischemia of the tumor tissue and increases production of angiogenic factors in patients with hepatocellular carcinoma (HCC). Lenvatinib can inhibit the expression...
4.
Chen R, Li Y, Song K, Li L, Shen C, Ma P, et al.
J Gastrointest Oncol
. 2022 May;
13(2):780-786.
PMID: 35557575
Background: The efficacy of transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) is limited. There are insufficient data on TACE-lenvatinib sequential therapy for HCC with...
5.
Wei G, Chen J, Jing Z, Li Y, Li Z, Zheng W, et al.
J Colloid Interface Sci
. 2021 Nov;
608(Pt 2):1355-1365.
PMID: 34742058
Mitochondria are appealing targets in cancer therapy for providing a suitable microenvironment and energy supply. Herein, we constructed a glycosylated poly(amido amine)/celastrol (PAMAM/Cel) complex for hypoxia-activated mitochondria-specific drug delivery and...
6.
Ma P, Wei G, Chen J, Jing Z, Wang X, Wang Z
Drug Deliv
. 2021 Oct;
28(1):2256-2267.
PMID: 34668823
Purpose: Mitochondria are closely correlated with the proliferation and metastasis of tumor for providing suitable micro-environment and energy supply. Herein, we construct a glucose transporter 1 (GLUT1) targeting and hypoxia...
7.
Chen J, Ning E, Wang Z, Jing Z, Wei G, Wang X, et al.
Drug Deliv
. 2021 Jun;
28(1):1389-1396.
PMID: 34180752
Sarcoma represents one of the most common malignant tumors with poor treatment outcomes and prognosis. Docetaxel (DTX) is acknowledged as one of the most important chemotherapy agents. The aim of...
8.
Zheng W, Sun G, Chen J, Li Z, Zhang T, Wei G, et al.
J Ethnopharmacol
. 2021 Jan;
270:113785.
PMID: 33422653
Ethnopharmacological Relevance: The Scutellariae Radix (SR) and Coptidis Rhizoma (CR) herb couple is widely used in traditional Chinese medicine prescriptions for the treatment of diabetes mellitus due to its interaction...
9.
Ma P, Chen J, Qu H, Li Y, Li X, Tang X, et al.
Drug Deliv
. 2020 Oct;
27(1):1412-1424.
PMID: 33096947
The tumor-derived and transcatheter arterial chemoembolization (TACE) induced hypoxia microenvironment is closely related to the poor prognosis of hepatocellular carcinoma (HCC). In this study, hypoxia-activated prodrug TH-302 loaded poly(lactic-co-glycolic acid)...
10.
Li Z, Chen J, Gao X, Zhang T, Zheng W, Wei G, et al.
J Sep Sci
. 2020 Apr;
43(13):2690-2707.
PMID: 32246812
Jiao-Tai-Wan, which is composed of Coptis Rhizoma and Cinnamon Cortex, has been recently used to treat type 2 diabetes. Owing to lack of data on its prototypes and metabolites, elucidation...